Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenprocoumon. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 known ✓ | Q9BQB6 | 3/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 9/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | ALB | P02768 | 1/20 | 0.73 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.73 |
| ▸ | NQO1 | P15559 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenprocoumon SCHEMBL24500477 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| Phenprocoumon SCHEMBL29392123 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| Phenprocoumon SCHEMBL24500472 | 1.00 | CYP2C9 (1.00) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL7351110 | 0.93 | CYP2C9 (0.87) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL8042698 | 0.92 | CYP2C9 (0.86) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| Warfarin SCHEMBL13724154 | 0.91 | CYP2C9 (0.90) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL7406235 | 0.91 | CYP2C9 (0.82) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL7350773 | 0.91 | CYP2C9 (0.82) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL8868104 | 0.91 | CYP2C9 (0.82) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL7348669 | 0.90 | CYP2C9 (0.81) | CYP2C9VKORC1HSD17B10KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7480 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4651828-A1 | DEVICE FOR ENDOVASCULAR DRUG DELIVERY AND USE THEREOF | Julius-Maximilians-Universität Würzburg, in Vertretung des Freistaates Bayern (DE) | 2025-11-26 | — | — | EP | claimed |
| US-20250333462-A1 | PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS | CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS (DE) | 2025-10-30 | — | — | US | claimed |
| US-20250326778-A1 | PYRAZOLE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS | RIGEL PHARMACEUTICALS, INC. (US) | 2025-10-23 | — | — | US | claimed |
| EP-3938040-B1 | VITAMIN K2 IN COMBINATION WITH ANTICOAGULANTS FOR USE IN TREATING MUSCLE SORENESS | LESAFFRE & CIE (FR) | 2025-05-21 | — | — | EP | claimed |
| EP-3823660-B1 | PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS | UNIV DER JOHANNES GUTENBERG UNIV MAINZ (DE) | 2025-05-07 | — | — | EP | claimed |
| US-12269021-B2 | Artificial protein catalyst | GLYTECH, INC. (JP) | 2025-04-08 | — | — | US | claimed |
| US-20250034100-A1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS INC (US) | 2025-01-30 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024176961-A1 | PROTEIN RECOGNIZING K-Ras GENE MUTATION CANCER | 国立研究開発法人理化学研究所 | 2024-08-29 | — | — | WO | claimed |
| EP-0797424-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1997-10-01 | — | — | EP | claimed |
| US-5629209-A | Method and apparatus for detecting viscosity changes in fluids | BRAUN BIOSYSTEMS, INC. | 1997-05-13 | — | — | US | claimed |
| CN-1137748-A | Gas used as local and subcutaneous transmission carrier and microspheres filled with gas precursor | IMARX PHARMACEUTICAL CORP (US) | 1996-12-11 | — | — | CN | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1996018370-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1996-06-20 | — | — | WO | claimed |
| EP-0682663-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-22 | — | — | EP | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| WO-1994018188-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | THE UPJOHN COMPANY (US) | 1994-08-18 | — | — | WO | claimed |
| US-5077281-A | Anticoagulants | BIOLINK CORPORATION | 1991-12-31 | — | — | US | claimed |
| US-4334020-A | Method of producing L-glutamic acid by fermentation | AJINOMOTO COMPANY INCORPORATED (JP) | 1982-06-08 | — | — | US | claimed |